Author response for 'Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial'

Autor:	Stephen J. Nicholls, Gregory G. Schwartz, Hiddo J.L. Heerspink, Arlette Weichert, Jeroen V. Koomen, Anders Svensson, Ilse C. Schrieks, A. Michael Lincoff, Diederick E. Grobbee, Jasper Stevens, Hans Wedel
Rok vydání:	2019
Předmět:	medicine.medical_specialty chemistry.chemical_compound Aleglitazar chemistry business.industry medicine Intensive care medicine business
DOI:	10.1111/dom.13862/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::de7a1664348643f81c082eccee555ed2 https://doi.org/10.1111/dom.13862/v2/response1 Zobrazit plný text záznamu